{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:46:56Z","timestamp":1792597616452,"version":"4.5.0"},"reference-count":5,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"abstract":"<jats:p>This case report describes a woman in her 20s who presented with persistent, symptomatic truncal Darier disease and was treated with topical trametinib.<\/jats:p>","DOI":"10.1001\/jamadermatol.2026.3103","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:34Z","timestamp":1792594834000},"source":"Crossref","is-referenced-by-count":0,"title":["Low-Concentration Topical Trametinib for Refractory Darier Disease"],"prefix":"10.1001","author":[{"given":"Diego","family":"Soto-Garc\u00eda","sequence":"first","affiliation":[{"name":"Dermatology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Inflammatory and Infectious Diseases and Immune Disorders Area, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Susana Fortes","family":"G\u00f3nzalez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Castro-Luaces","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Innovation in Clinical Pharmacy Research Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tom\u00e9-Espi\u00f1eira","sequence":"additional","affiliation":[{"name":"Dermatology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Inflammatory and Infectious Diseases and Immune Disorders Area, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"S\u00e1nchez-Espinel","sequence":"additional","affiliation":[{"name":"Inflammatory and Infectious Diseases and Immune Disorders Area, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain"},{"name":"Inmunology Group, Centro de Investigaci\u00f3n en Nanomateriais e Biomedicina, Vigo University, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1frica","family":"G\u00f3nzalez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Inflammatory and Infectious Diseases and Immune Disorders Area, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain"},{"name":"Inmunology Group, Centro de Investigaci\u00f3n en Nanomateriais e Biomedicina, Vigo University, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Garc\u00eda-Doval","sequence":"additional","affiliation":[{"name":"Dermatology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain"},{"name":"Inflammatory and Infectious Diseases and Immune Disorders Area, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"3","key":"dlo260015r1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/bjd\/ljaf468","article-title":"Darier disease is a syndromic epidermal differentiation disorder.","volume":"194","author":"Dodiuk-Gad","year":"2026","journal-title":"Br J Dermatol"},{"issue":"18","key":"dlo260015r2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170739","article-title":"Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease.","volume":"8","author":"Zaver","year":"2023","journal-title":"JCI Insight"},{"issue":"2","key":"dlo260015r3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/bjd\/ljaf160","article-title":"Trametinib as a promising therapy for Darier disease: case report.","volume":"193","author":"Soto-Garc\u00eda","year":"2025","journal-title":"Br J Dermatol"},{"issue":"4","key":"dlo260015r4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/pde.15903","article-title":"Topical trametinib for agminated Spitz nevi harboring HRAS mutation.","volume":"42","author":"Parsons","year":"2025","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"dlo260015r5","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.346","article-title":"Safety and tolerability of topical trametinib in rosacea: results from a phase I clinical trial.","volume":"4","author":"Wladis","year":"2024","journal-title":"Skin Health Dis"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2855606\/jamadermatology_sotogarca_2026_lo_260015_1792006445.3208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:35Z","timestamp":1792594835000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2855606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2026.3103","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}